Navigation Links
The Quantum Group Extends CEO's Employment Agreement
Date:3/28/2008

Secures full ownership of patent pending technologies

WELLINGTON, Fla., March 28 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (Amex: QGP, QGP.WSA, QGP.WSB) (http://www.QuantumMD.com) announced today that the Board of Directors and Noel J. Guillama, Quantum founder, President and Chief Executive Officer; have reached an agreement to amend his existing employment agreement to, among other things, extend his term of employment with the Company. The terms of the agreement are described in the Company's Current Report on Form 8-K filed on March 28, 2008.

Dr. Jose de la Torre, Chairman of the Compensation and Options Committee of The Quantum Group Board of Directors, commented, "We are thrilled to have reached this agreement which secures the continued leadership of Noel Guillama for Quantum. His vision, dedication, and experience established the Company five years ago and remain the catalyst for the continued progress of the organization."

Mr. Guillama further commented, "I am happy to receive this vote of confidence from our Board of Directors and expect that I will spend the peak of my professional years building this Company which I truly believe will be the changing force in the healthcare industry. Having previously built one of the healthcare industry leaders in the state of Florida, my personal goal has evolved to build the largest Company in this sector in Florida in the next decade."

The Company further announced that it has received full ownership of a number of recently filed provisional business process patents previously developed by Mr. Guillama.

About The Quantum Group, Inc.

The Quantum Group is a Florida-based organization. The Company builds and manages healthcare systems and offers consulting and outsourcing services to the nation's largest and fastest growing industry- healthcare.

The Company is leveraging leading-edge technology with the development and execution of a series of innovative patent-pending technology initiatives (including patent-pending business processes) designed to make Quantum one of the state's leading providers of business solutions for the healthcare industry. Through its growing number of over 1,800 contracted physicians and managed care relationships in the state of Florida, the Company believes it is positioned to bring increased efficiencies to the Florida healthcare industry.

Certain statements contained in this news release, which are not based on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the respective company's Securities and Exchange Commission 10-KSB, 10-QSB, S-8 and 8-K filings (and amendments thereto) that may cause actual results to materially differ from projections. Forward-looking statements can be identified by the use of words such as "expects," "plans," "will," "may," "anticipates," "believes," "should," "intends," "estimates" and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by these forward-looking statements. Such risk factors include, without limitation, the ability of the Company to properly execute its business model, to raise substantial and immediate additional capital to implement its business model, to attract and retain executive, management and operational personnel, to negotiate favorable current debt and future capital raises, to negotiate favorable agreements with a diversified provider base and to continue to supply the services needed by its HMO clients as well physician clients. The Company does not undertake any obligation to publicly update any forward-looking statements. There can be no assurance that the provisional patents discussed in this press release will be granted by the US Patent and Trademark Office, or, if they are granted, they will not be challenged by third parties, or if not that we will be able to effectively use or commercialize such patents and/or we may not have the resources to deploy such technology. As a result, investors should not place undue reliance on these forward-looking statements.

FOR MORE INFORMATION, PLEASE CONTACT:

BPC Financial Marketing

John Baldissera

800.368.1217

Or

Danielle Amodio

Vice President Corporate Communications

The Quantum Group, Inc.

561.798.9800


'/>"/>
SOURCE The Quantum Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The Quantum Group Announces 1st Quarter Financial Results for Fiscal Year 2008
2. The Quantum Group Announces Strategic Technology Alliance
3. The Quantum Group to Present at the Jesup & Lamont Emerging Growth Stock Conference on February 28th
4. The Quantum Group Reports 4th Quarter and Year End Results for Fiscal Year 2007
5. The Quantum Group, Inc. Announces Separation of Units
6. Results promising for computational quantum chemical methods for drug development
7. The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol QGP
8. American Stock Exchange Lists the Common Stock and Units of The Quantum Group, Inc.
9. Quantum Foundation Makes a Half Million Dollars Available to Federally Qualified Health Centers
10. Quantum light beams good for fast technology
11. Texas Senator Kirk Watson Honored as Champion for Children by the AMERIGROUP Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
(Date:9/18/2017)... , Sept. 18, 2017 ... fields of bioinformatics and immune engineering, today ... protective avian influenza A (H7N9) vaccine. ... related to seasonal influenza and presents a ... on prior exposure to be effective. Using ...
(Date:9/12/2017)... Sept. 12, 2017   EcoVadis , the leading platform for environmental, ... first annual edition of its Global CSR Risk and Performance Index. The ... EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points across ... ... ...
Breaking Medicine Technology: